Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0012 Transporter Info | ||||
| Gene Name | ABCC3 | ||||
| Transporter Name | Multidrug resistance-associated protein 3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Cefamandole Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 456255 | ||||
| Docking Score | -10.11 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C18H18N6O5S2 | ||||
| Molecular Weight | 462.5 | ||||
| Canonical SMILES |
CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O
|
||||
| InChI |
InChI=1S/C18H18N6O5S2/c1-23-18(20-21-22-23)31-8-10-7-30-16-11(15(27)24(16)12(10)17(28)29)19-14(26)13(25)9-5-3-2-4-6-9/h2-6,11,13,16,25H,7-8H2,1H3,(H,19,26)(H,28,29)/t11-,13-,16-/m1/s1
|
||||
| InChIKey | OLVCFLKTBJRLHI-AXAPSJFSSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.9 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Delavirdine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5625 | ||||
| Docking Score | -10.012 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C22H28N6O3S | ||||
| Molecular Weight | 456.6 | ||||
| Canonical SMILES |
CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C
|
||||
| InChI |
InChI=1S/C22H28N6O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20/h4-8,13-15,24-26H,9-12H2,1-3H3
|
||||
| InChIKey | WHBIGIKBNXZKFE-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.4 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Cefoxitin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 441199 | ||||
| Docking Score | -9.818 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H17N3O7S2 | ||||
| Molecular Weight | 427.5 | ||||
| Canonical SMILES |
CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3
|
||||
| InChI |
InChI=1S/C16H17N3O7S2/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22)/t14-,16+/m1/s1
|
||||
| InChIKey | WZOZEZRFJCJXNZ-ZBFHGGJFSA-N | ||||
| Pharmaceutical Properties | Xlogp | 0 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 9 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.